These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16260051)

  • 1. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension.
    Affuso F; Palmieri EA; Di Conza P; Guardasole V; Fazio S
    Int J Cardiol; 2006 Apr; 108(3):429-31. PubMed ID: 16260051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension.
    Pepke-Zaba J; Beardsworth A; Chan M; Angalakuditi M
    Curr Med Res Opin; 2009 Oct; 25(10):2479-85. PubMed ID: 19686085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients.
    Tay EL; Geok-Mui MK; Poh-Hoon MC; Yip J
    Int J Cardiol; 2008 Apr; 125(3):416-7. PubMed ID: 17407795
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral tadalafil in pulmonary artery hypertension: a prospective study.
    Aggarwal P; Patial RK; Negi PC; Marwaha R
    Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tadalafil improves oxygenation in a model of newborn pulmonary hypertension.
    Tessler RB; Zadinello M; Fiori H; Colvero M; Belik J; Fiori RM
    Pediatr Crit Care Med; 2008 May; 9(3):330-2. PubMed ID: 18446109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil therapy for pulmonary arterial hypertension.
    Galiè N; Brundage BH; Ghofrani HA; Oudiz RJ; Simonneau G; Safdar Z; Shapiro S; White RJ; Chan M; Beardsworth A; Frumkin L; Barst RJ;
    Circulation; 2009 Jun; 119(22):2894-903. PubMed ID: 19470885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
    Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S
    Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
    Sakuma M; Shirato K
    Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.
    Bharani A; Patel A; Saraf J; Jain A; Mehrotra S; Lunia B
    Indian Heart J; 2007; 59(4):323-8. PubMed ID: 19126937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil (Adcirca) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245
    [No Abstract]   [Full Text] [Related]  

  • 12. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
    Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.
    Fischler M; Maggiorini M; Dorschner L; Debrunner J; Bernheim A; Kiencke S; Mairbäurl H; Bloch KE; Naeije R; Brunner-La Rocca HP
    Am J Respir Crit Care Med; 2009 Aug; 180(4):346-52. PubMed ID: 19520908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
    Kim HS; Park JH; Park SJ; Park JK; Lee HB
    Korean J Intern Med; 2007 Mar; 22(1):37-9. PubMed ID: 17427645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog.
    Serres F; Nicolle AP; Tissier R; Gouni V; Pouchelon JL; Chetboul V
    J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):129-33. PubMed ID: 16533328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil as treatment for idiopathic pulmonary arterial hypertension.
    de Carvalho AC; Hovnanian AL; Fernandes CJ; Lapa M; Jardim C; Souza R
    Arq Bras Cardiol; 2006 Nov; 87(5):e195-7. PubMed ID: 17396193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tadalafil: novel aspects of phosphodiesterase-5 inhibition in the treatment of pulmonary hypertension].
    Gaudó Navarro J; Sueiro Bendito A
    Arch Bronconeumol; 2011; 47 Suppl 7():26-31. PubMed ID: 23351473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we pursue pulmonary vasodilation in patients with COPD?
    Brusselle G
    Lancet Respir Med; 2014 Apr; 2(4):252-4. PubMed ID: 24717617
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension.
    Wong RC; Koh GM; Choong PH; Yip WL
    Int J Cardiol; 2007 Jul; 119(3):400-2. PubMed ID: 17064789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension.
    Nagaya N; Kyotani S; Uematsu M; Ueno K; Oya H; Nakanishi N; Shirai M; Mori H; Miyatake K; Kangawa K
    Circulation; 2004 Jan; 109(3):351-6. PubMed ID: 14718403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.